HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marisa Calabuig Selected Research

Antiviral Agents (Antivirals)

8/2017A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marisa Calabuig Research Topics

Disease

3Infections
09/2022 - 10/2008
3Neoplasms (Cancer)
09/2022 - 09/2019
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 05/2017
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019 - 01/2018
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2018 - 08/2017
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2022
1Hematologic Diseases (Blood Diseases)
09/2022
1Bacteremia
02/2022
1Sepsis (Septicemia)
02/2022
1COVID-19
10/2021
1Critical Illness (Critically Ill)
12/2019
1Myeloid Leukemia (Leukemia, Myelocytic)
09/2019
1Leukemia
10/2018
1Coinfection
08/2018
1Respiratory Tract Diseases (Respiratory Tract Disease)
08/2018
1Invasive Fungal Infections
03/2018
1Mycoses (Diseases, Fungus)
03/2018
1Carcinoma (Carcinomatosis)
01/2018
1Paramyxoviridae Infections (Parainfluenza)
08/2017
1Pharyngitis (Sore Throat)
08/2017
1Fever (Fevers)
08/2017
1Sinusitis
08/2017
1Virus Diseases (Viral Diseases)
08/2017
1Otitis
08/2017
1Tonsillitis
08/2017
1Heart Failure
07/2017
1Cardiomyopathies (Cardiomyopathy)
07/2017
1Disease Progression
05/2017
1Cytomegalovirus Infections (Inclusion Disease)
10/2008
1Peripheral Nervous System Diseases (PNS Diseases)
11/2006
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2006
1Multiple Myeloma
11/2006
1Venous Thrombosis (Deep-Vein Thrombosis)
11/2006
1Stroke (Strokes)
11/2006
1Thrombosis (Thrombus)
11/2006
1Thrombotic Stroke
11/2006

Drug/Important Bio-Agent (IBA)

3Azacitidine (5 Azacytidine)FDA Link
01/2021 - 09/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2022
1AntibodiesIBA
09/2022
1Monoclonal AntibodiesIBA
09/2022
1Pharmaceutical PreparationsIBA
02/2022
1Oxygen (Dioxygen)IBA
10/2021
1A-Form DNA (A-DNA)IBA
03/2020
1ceftolozaneIBA
12/2019
1CurcuminIBA
09/2019
1Vascular Endothelial Growth Factor CIBA
10/2018
1posaconazoleFDA Link
03/2018
1Itraconazole (Sporanox)FDA LinkGeneric
03/2018
1C-Reactive ProteinIBA
08/2017
1Antiviral Agents (Antivirals)IBA
08/2017
1Ribavirin (Virazole)FDA LinkGeneric
08/2017
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
07/2017
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2017
1Cytidine Monophosphate (CMP)IBA
07/2017
1AnthracyclinesIBA
07/2017
1Investigational DrugsIBA
05/2017
1HematinicsIBA
05/2017
1Lenalidomide (CC 5013)FDA Link
05/2017
1DNA (Deoxyribonucleic Acid)IBA
10/2008
1Thalidomide (Thalomid)FDA Link
11/2006

Therapy/Procedure

5Therapeutics
09/2022 - 10/2008
4Drug Therapy (Chemotherapy)
12/2019 - 11/2006
4Hematopoietic Stem Cell Transplantation
08/2018 - 10/2008
3Stem Cell Transplantation
08/2018 - 08/2017
1Patient Admission (Patient Admissions)
03/2018
1Radiotherapy
01/2018
1Aftercare (After-Treatment)
11/2006